Why Are ADHD Medications in Shortage? The DEA Quota Problem
Why are ADHD medications in shortage, four years after it started? The easy answer is demand. The harder answer is a federal quota system that measures demand by looking backward, and keeps getting the present wrong.
The FDA formally announced the Adderall shortage in October 2022. Teva, then the largest manufacturer, had fallen behind on production after labor disruptions. Demand then did what demand does under pressure: it shifted to the alternatives, and Vyvanse, Concerta, and the generics started running dry too. That is the origin story everyone tells. The reason it is still going on is stranger, and it lives inside the Drug Enforcement Administration.
Why are ADHD medications in shortage: the quota feedback loop
ADHD stimulants are Schedule II controlled substances, which means the DEA caps how much manufacturers can make each year through Aggregate Production Quotas. The law directs the DEA to size that ceiling to the country's estimated medical need. The problem is how the estimate is built: from past sales.
Policy researchers at the Brookings Institution have documented why this breaks. When the quota is the binding constraint on supply, sales cannot rise to meet demand, because sales only record what the quota allowed to be sold. The DEA then looks at those depressed numbers and reads them as lower need. It is a self-fulfilling prophecy of scarcity: the agency's own ceiling manufactures the evidence it uses to keep the ceiling low. Raising the ceiling is slow, and it treats some of the demand signal as misuse it does not want to accommodate.
In October 2025, the DEA did raise limits on the key ADHD ingredients, d-amphetamine, methylphenidate, and lisdexamfetamine, by up to 25 percent. Policy analysts cautioned the shortage might not end anyway, because quotas rest on outdated sales data and the rest of the supply chain has its own failure points.
The plot twist: factories did not even use their quota
Here is the finding that changed how I think about this. A March 2026 Yale study published in JAMA Health Forum looked at stimulant shortages in 2022 and 2023, a period when more than 70% of adults taking ADHD medications reported difficulty filling prescriptions. The researchers found that manufacturers produced only 70% of their allowed quota in 2022. The quota ceiling, in other words, was not the only binding constraint. Factories left a third of their permitted production on the table.
Why? Because the physical supply chain is alarmingly concentrated. One-third of the active pharmaceutical ingredients for the U.S. market came from a single facility, and another 30% came from just two or three sources. Raw amphetamine and precursor imports fell sharply at the same time smaller manufacturers cut production. The Yale team called for diversifying supply sources and strengthening domestic manufacturing. Blame the quota, yes, but do not stop there: a quota increase cannot conjure ingredients that no longer arrive.
What actually helps patients right now
The system-level fixes are slow. The patient-level moves are not. The National Institutes of Health documented prescription growth that the quota system never absorbed: among patients aged 22 to 44, Adderall prescriptions jumped 7.4% between 2019 and 2020, then another 15.1% the following year. That demand is not going away, so the practical advice stands:
- Call more pharmacies. Stock varies wildly by location and chain. The pharmacy two miles away may have what yours does not.
- Ask about substitutions. Your doctor can prescribe an alternative formulation or delivery mechanism your insurance covers. Never make this call yourself.
- Check the official list. The FDA Drug Shortages Database shows whether your medication is in a national shortage or a local stocking gap. The answer changes your strategy.
- Watch the quota calendar. The DEA sets quotas annually, so supply tends to shift in waves. A shortage that looks permanent in March can ease by fall.
The shortage is not one failure. It is a quota system that reads its own scarcity as low demand, layered over factories that could not produce what they were allowed to, layered over demand that kept growing. Fixing any one layer helps. Fixing all three ends it.
Frequently asked questions
Why are ADHD medications in shortage?
A mix of rising demand, DEA production quotas for Schedule II stimulants, manufacturing disruptions, and concentrated supply chains. Prescriptions surged during the pandemic while quotas stayed flat, and the DEA builds quotas from past sales, which understates demand during a shortage.
What is the DEA quota for ADHD medications?
Each year the DEA sets Aggregate Production Quotas limiting how much of each Schedule II controlled substance, including amphetamine and methylphenidate, manufacturers may produce. In October 2025 the DEA raised limits on key ADHD ingredients by up to 25 percent, though industry analysts caution shortages may continue because the system still relies on outdated sales data.
When did the Adderall shortage start?
The FDA formally announced a shortage of Adderall and its generics in October 2022, triggered by manufacturing delays at Teva, then the largest producer. It spread to Vyvanse, Concerta, and other stimulants as demand shifted to alternatives.
Did manufacturers use their full DEA quota?
No. A 2026 Yale study in JAMA Health Forum found manufacturers produced only 70% of their allowed quota in 2022. The same study found supply highly concentrated: one-third of active pharmaceutical ingredients came from a single facility. The quota mattered, but supply chain fragility caused as much of the shortage as the regulation did.
What should I do if my ADHD medication is unavailable?
Call multiple pharmacies, since stock varies by location. Ask your doctor about therapeutic substitutions your insurance covers. Check the FDA Drug Shortages Database to see whether it is a national shortage or a local gap. Do not skip doses without talking to your prescriber about a plan.
Related reading: How to Check If Your Drug Is on the FDA Shortage List · Your Prescription Is on Backorder: What to Do Next · How Long Do Drug Shortages Last? The FDA Data